L.J. Altfest & Co’s VanEck Pharmaceutical ETF PPH Stock Holding History

L.J. Altfest & Co’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-42,107	Closed	-$3.27M	–	286
2022 Q4	$3.27M	Sell	42,107 -17,780	-30%	-$1.31M	0.54%	38
2022 Q3	$4.03M	Sell	59,887 -11,355	-16%	-$836K	0.76%	23
2022 Q2	$5.47M	Sell	71,242 -18,174	-20%	-$1.42M	0.98%	22
2022 Q1	$7.13M	Buy	89,416 +37,634	+73%	+$2.88M	1.27%	17
2021 Q4	$3.98M	Buy	+51,782	New	+$3.85M	0.76%	28

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

VAS

Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return

L.J. Altfest & Co's PPH Position: Q1 2023 in Review

L.J. Altfest & Co sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2023, closing a stake of 42,107 shares — an estimated $3.27M sold.

L.J. Altfest & Co first reported a position in PPH in Q4 2021 and held it in 5 quarters. The position peaked at $7.13M in Q1 2022. 106 funds tracked by Wall St. Rank hold PPH as of Q1 2023.

L.J. Altfest & Co reported no remaining VanEck Pharmaceutical ETF position as of Q1 2023 after selling out during the quarter.
L.J. Altfest & Co sold 42,107 VanEck Pharmaceutical ETF shares in Q1 2023, an estimated $3.27M.
L.J. Altfest & Co first reported a position in VanEck Pharmaceutical ETF in Q4 2021 and held it in 5 quarters.
L.J. Altfest & Co's VanEck Pharmaceutical ETF position peaked at $7.13M in Q1 2022.
106 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2023.

Based on L.J. Altfest & Co's 13F filing for Q1 2023, filed 20 Apr 2023.